ea0077op3.3 | Reproductive and Neuroendocrinology | SFEBES2021
MacFarlane James
, Kourlouri Olympia
, Gillett Daniel
, Senanayake Russell
, Santarius Thomas
, Tysome James
, Donnelly Neil
, Mendichovszky Iosif
, Cheow Heok
, Mannion Richard
, Bashari Waiel
, Gurnell Mark
Background: In a sub-group of patients with newly diagnosed pituitary adenomas, conventional MRI will fail to confidently localise the tumour. The role of molecular imaging for these patients is increasingly being recognised, both in terms of confirming diagnosis and in guiding targeted therapy; 11C-Methionine PET co-registered with volumetric MRI (Met-PET/MRCR) can enhance decision making in this group of patients. However, in some cases distinguishing t...